The BRG1 degrader, AU-15330, demonstrated inhibitory effects on cell invasion across various cancer types, including skin cancer, ccRCC, and colon cancer, without impacting cell proliferation (Fig. 7i and Supplementary Fig. 10l, m). This evidence concerns the gene SMARCA4 and malignant colon neoplasm.